The combination of Bristol Myers Squibb cancer drugs Opdivo and Yervoy landed FDA approvals for the first-line treatment of colorectal cancer and hepatocellular carcinoma. Several other products also expanded their approved uses in our recap of recent regulatory news.The pairing of two Bristol Myers Squibb immunotherapies is now permitted for the first-line treatment of two […]
